Source: http://www.google.com/patents/US6757563?ie=ISO-8859-1&dq=6,263,507
Timestamp: 2015-03-02 15:57:37
Document Index: 444890351

Matched Legal Cases: ['art.\n16', 'art.\n17', 'art.\n20', 'art.\n21', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115']

Patent US6757563 - Cardiac rhythm management system with ultrasound for autocapture or other ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA cardiac rhythm management system provides ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart, and for adjusting an energy of the stimulation based on the observed response from the heart. A first ultrasound element is disposed on a lead...http://www.google.com/patents/US6757563?utm_source=gb-gplus-sharePatent US6757563 - Cardiac rhythm management system with ultrasound for autocapture or other applicationsAdvanced Patent SearchPublication numberUS6757563 B2Publication typeGrantApplication numberUS 10/321,119Publication dateJun 29, 2004Filing dateDec 17, 2002Priority dateApr 19, 1999Fee statusPaidAlso published asUS6298269, US6539262, US20020082645, US20030069608, WO2000062858A2, WO2000062858A3Publication number10321119, 321119, US 6757563 B2, US 6757563B2, US-B2-6757563, US6757563 B2, US6757563B2InventorsRobert J. SweeneyOriginal AssigneeCardiac Pacemakers, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (54), Non-Patent Citations (4), Referenced by (7), Classifications (4), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetCardiac rhythm management system with ultrasound for autocapture or other applications
US 6757563 B2Abstract
A cardiac rhythm management system provides ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart, and for adjusting an energy of the stimulation based on the observed response from the heart. A first ultrasound element is disposed on a lead in the heart. A second ultrasound element is disposed elsewhere in the heart or in the implanted device. An autocapture determination circuit determines whether motion of the heart chamber indicates a contraction in response to the stimulation, and adjusts the stimulation energy to provide only that energy which is needed to obtain capture. This saves energy, prolonging the life of the implanted device, minimizing the risk and expense to patient associated with early explantation and replacement of the implanted device. Other applications include using ultrasound for (1) determining the strength of heart contractions (2) determining dissociation between electrical and mechanical heart activity, (3) determining the volume of the heart, (4) determining the origin of sensed intrinsic electrical heart activity signals, (5) recognizing particular arrhythmias (6) disrupting cell membranes for lowering stimulation thresholds, (7) controlling the delivery of a steroid, and (8) obtaining blood flow information.
What is claimed is: 1. A cardiac rhythm management system comprising:
a lead, comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising a first ultrasonic element; and an electronics unit coupled to the proximal end of the lead, the electronics unit comprising: an ultrasound driving circuit; and a signal processing circuit that processes a signal that is based on ultrasound, and in which the signal processing circuit includes an autocapture determination module that determines, using information from the signal that is based on ultrasound, whether a stimulus triggered a resulting heart contraction. 2. The system of claim 1, further comprising:
an electrode adapted for being associated with a portion of a heart; and a sensing circuit for detecting intrinsic electrical heart activity based on at least one electrogram signal received from the electrode. 3. The system of claim 2, in which the signal processing circuit detects occurrences of heart activity using both the ultrasound and the electrogram signal.
4. The system of claim 1, further comprising a programmer remote from the electronics unit.
5. A cardiac rhythm management system comprising:
an electronics unit, sized and shaped to permit implantation in a human subject, the electronics unit comprising: an ultrasound driving circuit; and means for determining, using information from returned ultrasound, whether an electrical stimulus triggered a resulting heart contraction. 6. The system of claim 5, further comprising a lead coupled to the electronics unit, the lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising a first ultrasonic element.
7. The system of claim 5, further comprising a lead coupled to the electronics unit, the lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising an electrode for delivering the electrical stimulus.
8. A cardiac rhythm management system comprising:
an electronics unit, sized and shaped to permit implantation into a human subject, the electronics unit comprising: an ultrasound driving circuit; and a signal processing circuit that processes a signal that is based on ultrasound, and in which the signal processing circuit includes a slope detection module that provides, using information from the signal that is based on ultrasound, an indication of a strength of a mechanical heart contraction. 9. The system of claim 8, further comprising a lead, coupled to the electronics unit, the lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising a first ultrasonic element.
10. A cardiac rhythm management system comprising:
an electronics unit, sized and shaped to permit implantation into a human subject, the electronics unit comprising: an ultrasound driving circuit; and means for determining a strength of a mechanical heart contraction using information from a signal that is based on ultrasound. 11. A cardiac rhythm management system comprising:
an electronics unit coupled to the proximal end of the lead, the electronics unit sized and shaped to permit implantation into a human subject, the electronics unit comprising: an ultrasound driving circuit; and a signal processing circuit that processes a signal that is based on ultrasound, and in which the signal processing circuit includes an amplitude detection module that detects an amplitude of the signal that is based on ultrasound. 12. The system of claim 11, in which the amplitude detection module provides an indication of the volume of a mechanical heart contraction using the detected amplitude of the signal that is based on ultrasound.
13. The system of claim 11, further comprising a lead, comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising a first ultrasonic element.
an electronics unit, sized and shaped to permit implantation into a human subject, the electronics unit configured to be coupled to an electrode associated with a heart and to an ultrasonic element associated with the heart, the electronics unit comprising: an ultrasound driving circuit; a signal processing circuit that processes a signal that is based on returned ultrasound; a sensing circuit to detect intrinsic electrical heart activity using at least one electrogram signal received from the electrode, and in which the signal processing circuit is configured to detect a dissociation between (1) an occurrence of heart activity detected using the signal that is based on returned ultrasound and (2) an occurrence of heart activity detected using the at least one electrogram signal. 15. The system of claim 14, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the ultrasonic element associated with the heart.
16. The system of claim 14, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the electrode associated with the heart.
17. The system of claim 14, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the electrode associated with the heart and the ultrasonic element associated with the heart.
an electronics unit, sized and shaped to permit implantation into a human subject, the electronics unit configured to be coupled to an electrode associated with a heart and to an ultrasonic element associated with the heart, the electronics unit comprising: an ultrasound driving circuit; a sensing circuit to detect intrinsic electrical heart activity using at least one electrogram signal received from the electrode; and means, coupled to the sensing circuit, for detecting any dissociation between (1) an occurrence of heart activity detected using returned ultrasound and (2) an occurrence of heart activity detected using the at least one electrogram signal. 19. The system of claim 18, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the ultrasonic element associated with the heart.
20. The system of claim 18, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the electrode associated with the heart.
21. The system of claim 18, further comprising a lead comprising a distal end and a proximal end, the distal end of the lead adapted for being disposed in or about a heart, the distal end of the lead comprising the electrode associated with the heart and the ultrasonic element associated with the heart.
This application is a continuation of U.S. application Ser. No. 09/950,276, filed on Sep. 10, 2001, now issued as U.S. Pat. No. 6,539,262, which is a continuation of U.S. application Ser. No. 09/294,641, filed on Apr. 19, 1999, now issued as U.S. Pat. No. 6,298,269, the specifications of which are hereby incorporated by reference.
This invention relates generally to cardiac rhythm management systems and particularly, but not by way of limitation, to a cardiac rhythm management system with ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart.
One problem faced by cardiac rhythm management systems is providing therapy at appropriate energy levels. In pacers, for example, pacing stimulations must have sufficient energy to capture the heart, that is, to initiate a resulting heart contraction. Delivering too much energy, however, will shorten the life of the battery powered implantable device. This, in turn, results in performing an earlier surgical explantation and replacement procedure, with its attendant risks and costs, both for the procedure and for the replacement device. Thus, there is a need to determine whether a cardiac rhythm management system is providing therapy at appropriate energy levels.
This document describes, among other things, a cardiac rhythm management system with ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart, and for adjusting an energy of the stimulation based on the observed response from the heart. An autocapture determination circuit determines whether motion of the heart chamber indicates a contraction in response to the stimulation, and adjusts the stimulation energy to provide only that energy which is needed to ensure reliable capture. This saves energy, prolonging the life of the implanted device, minimizing the risk and expense to patient associated with early explantation and replacement of the implanted device.
In one embodiment, the cardiac rhythm management system includes a lead. The lead includes a distal end and a proximal end. The distal end of the lead is adapted for being disposed in or about a heart. The distal end of the lead includes a first ultrasonic element. An electronics unit is coupled to the proximal end of the lead. The electronics unit includes an ultrasound driving circuit and a signal processing circuit that includes an autocapture determination circuit. In a first further embodiment, a second ultrasonic element is adapted for being disposed in a heart chamber different from the first ultrasonic element. In a second further embodiment, a second ultrasonic element is in a case carrying the electronics unit.
This document also discloses using the ultrasound for applications other than the ultrasound capability, including but not limited to: (1) determining the strength of heart contractions, such as from the slope of a signal transduced from the ultrasound, (2) determining dissociation between electrical and mechanical heart activity, (3) determining the volume of the heart, such as at different times during the cardiac cycle, (4) determining the origin of sensed intrinsic electrical heart activity signals based at least in part on information obtained from the ultrasound, (5) recognizing particular arrhythmias based at least in part on information obtained from the ultrasound, (6) delivering ultrasound for disrupting cell membranes for lowering stimulation thresholds, (7) using ultrasound to control the delivery of a steroid, and (8) obtaining blood flow information based at least in part on information obtained from the ultrasound. Other aspects of the invention will be apparent on reading the following detailed description of the invention and viewing the drawings that form a part thereof.
FIG. 2 is a schematic drawing illustrating generally one embodiment of portions of a lead and an implanted device.
FIG. 3 is a schematic drawing illustrating generally one embodiment of portions of a lead, an implanted device, and circuits included in the implanted device.
FIG. 4 is a schematic drawing, illustrating generally one embodiment of transmission of ultrasound from the device to the ultrasonic element disposed in the heart.
FIG. 5 is a schematic drawing, illustrating generally an embodiment including a first ultrasonic element in a first heart chamber and a second ultrasonic element disposed in another heart chamber.
FIG. 6 is a schematic drawing illustrating generally an embodiment including a first ultrasonic element in a first heart chamber, a second ultrasonic element in another heart chamber, and a third ultrasonic element in the implanted device.
FIG. 7 is a schematic drawing illustrating generally an embodiment including a single ultrasonic element in a first heart chamber for both providing and receiving ultrasound energy.
FIG. 8 is a schematic drawing illustrating generally an embodiment providing capabilities other than autocapture.
This document describes, among other things, a cardiac rhythm management system with ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart, and for adjusting an energy of the stimulation based on the observed response from the heart.
FIG. 1 is a schematic drawing illustrating generally, by way of example, but not by way of limitation, one embodiment of portions of a cardiac rhythm management system 100 and an environment in which it is used. In FIG. 1, system 100 includes an implantable cardiac rhythm management device 105, which is coupled by an intravascular endocardial lead 110 to a heart 115 of patient 120. System 100 also includes an external programmer 125 providing wireless communication with device 105 using a telemetry device 130. Lead 110 includes a proximal end 135, which is coupled to device 105, and a distal end 140, which is coupled to one or more portions of heart 115.
FIG. 2 is a schematic drawing illustrating generally, by way of example, but not by way of limitation, one embodiment of portions of lead 110 and device 105, with distal end 140 of lead 110 being disposed in right ventricle 200 of heart 115. Right atrium 205, left atrium 210, and left ventricle 215 are also illustrated. Distal end 140 of lead 110 includes at least one electrode, such as pacing tip electrode 220 and pacing ring electrode 225, for providing bipolar pacing stimulations to heart 115. Tip electrode 220 is coupled to device 105 by a first wire carried in lead 110. Ring electrode 225 is coupled to device 105 by a second wire carried in lead 110. Distal end 140 of lead 110 also includes a piezoelectric first ultrasonic element 230, located near ring electrode 225 and tip electrode 220, for transmitting ultrasound, receiving ultrasound, or both transmitting and receiving ultrasound. Device 105 includes a piezoelectric second ultrasonic element 235 for transmitting ultrasound, receiving ultrasound, or both transmitting and receiving ultrasound. In one embodiment, second ultrasonic element 235 is attached within a hermetically sealed case that encloses the electronic and other components of device 105. In another embodiment, second ultrasonic element 235 is included within a header portion extending from the hermetically sealed case, as illustrated in FIG. 6.
FIG. 3 is a schematic drawing illustrating generally, by way of example, but not by way of limitation, portions of heart 115, including first ultrasound element 230 and at least one electrode 220 disposed therein, and device 105, including second ultrasound element 235. In this embodiment, an electrical driving signal at ultrasonic frequencies (e.g., 1-100 microsecond pulses of a 10 MHZ ultrasound signal) is provided by driver 300, in device 105, through conductors in lead 110 to first ultrasound element 230. Transduced from this signal, first ultrasound element 230 emits ultrasound energy within heart 115. This ultrasound energy is received by second ultrasound element 235 in device 105, which transduces it into an electrical signal that is provided, at node 305, to signal processor 310. Signal processor 310 includes amplification, demodulation, filter, analog-to-digital (A/D) conversion, digital-to-analog (D/A) conversion, memory, and other circuits for extracting and storing information obtained from the transduced ultrasound signal from second ultrasound element 235. Portions of these circuits may be implemented as one or more sequences of instructions carried out on a microprocessor or other microcontroller.
The signal at node 305 includes information about the movement of the heart chamber in which first ultrasound element 230 is disposed. Therapy circuit 315 delivers a pacing pulse stimulation via lead 110 to electrode 220 in right ventricle 200 (for example) of heart 115. Such pacing stimuli are usually delivered at a time when the particular heart chamber is in a relaxed passive state and is being filled with blood. If the delivered pacing stimulus captures the heart, myocardial tissue near pacing site of electrode 220 begins to contract. If the delivered pacing stimulus does not capture the heart, such tissue does not begin to contract.
In one embodiment, system 100 uses a measurement of the transit time of the ultrasound energy between first ultrasound element 230, which is disposed in right ventricle 200, and second ultrasound element 235, in device 105 located at a reference point elsewhere in patient 120 outside heart 115. The transit time of the ultrasound energy provides an indication of the physical distance between first ultrasound element 230 and second ultrasound element 235. Variations in this distance represent movement of right ventricle 200, in which first ultrasound element 230 is disposed, relative to device 105. Such movement of right ventricle 200 results from contractions caused by the pacing stimulations or intrinsic electrical heart activity. The presence or absence of such movement during an appropriate time period following the pacing stimulation indicates a resulting capture and no capture, respectively.
By monitoring movement over that portion of the cardiac cycle following the pacing stimulation, system 100 determines whether the pacing stimulation captured the heart. In one embodiment, the movement observed (during an appropriate time window initiated by the pacing stimulation) is compared to a threshold value, which corresponds to the movement expected even in the absence of an evoked contraction. If the movement observed exceeds this threshold value, then system 100 indicates that capture was successfully obtained. If, upon expiration of the appropriate time period, system 100 determines that the heart was not captured, then system 100 issues a second pacing stimulation, of sufficiently large energy to obtain capture. In another embodiment, movement is monitored over a plurality of cardiac cycles to determine whether, over a period of time, the pacing stimulations capture the heart. For each pacing stimulation, if no capture is indicated upon expiration of the time window triggered by the pacing stimulation, then a second pacing stimulation of sufficient energy to obtain capture is delivered.
One autocapture method of determining the appropriate energy level starts with the delivery of a high energy pacing stimulation to the heart. The energy is reduced during subsequent pacing stimulations (e.g., by reducing pacing amplitude or pulse duration), until the movement observed indicates that capture was not obtained. System 100 then increases the energy back to a level known to be adequate to obtain capture. This autocapture determination can be made intermittently or, alternatively, may represent a particular mode that can be set to operate continuously.
In another embodiment, system 100 uses a Doppler shift measurement of movement of the right ventricle 200. In this embodiment, the change in frequency of the ultrasound signals transmitted by the first ultrasound element 230 (and received by second ultrasound element 235) is frequency demodulated to represent movement of right ventricle 200 as it contracts and expands. A higher frequency signal represents motion of the first ultrasound element 230, in right ventricle 200, toward device 105. A lower frequency signal represents motion of the first ultrasound element 230, in right ventricle 200, away from device 105. In a further embodiment, both transit time and Doppler shift measurements (or other like measurements) are used.
System 100 includes an autocapture determination module (e.g., a sequence of instructions carried out on the microcontroller in signal processor 310) that determines whether motion of the heart chamber indicates a contraction in response to the delivered stimulation. The autocapture determination module adjusts the stimulation energy (either the amplitude of the pacing voltage pulse or the time period, i.e., pulsewidth, during which the pacing stimulation is being delivered) to provide only that stimulation energy which is needed to obtain capture. As a result, the energy delivered by therapy circuit 315 is optimized such that, over many such cardiac cycles, pacing stimulations are delivered at optimized reduced energies. This, in turn, prolongs the life of power source 320 (e.g., a battery) and the implanted device 105, minimizing the risk and expense to patient 120 associated with early explantation and replacement of device 105.
FIG. 4 is a schematic drawing, similar to FIG. 3, illustrating generally, by way of example, but not by way of limitation, another embodiment of portions of system 100 in which driver 300 is coupled to second ultrasound element 235 for emitting ultrasound energy received by first ultrasound element 230 in heart 115, where it is transduced into an electrical signal that is provided, at node 305, to signal processor 310. This embodiment also contemplates one or more of transit time, Doppler shift, or other like measurements of the motion of first ultrasound element 230 to detect whether a stimulation from therapy circuit 315 obtains a resulting contraction of heart 115.
FIG. 5 is a schematic drawing, including aspects that are similar to those described with respect to FIG. 2, illustrating generally, by way of example, but not by way of limitation, another embodiment of portions of system 100 in which device 105 is also coupled to a second heart chamber, i.e., right atrium 205, through lead 110B. Second lead 110B also includes tip electrode 220B, ring electrode 225B, and second ultrasonic element 230B. In this embodiment, a stimulation is delivered to right ventricle 200 and its movement is detected by providing ultrasound at first ultrasound element 230A and receiving the ultrasound at second ultrasound element 230B (or vice versa) to determine whether the stimulation obtained a resulting contraction of right ventricle 200. Similarly, a stimulation is delivered to right atrium 205 and its movement is detected by providing ultrasound at second ultrasound element 230B and receiving the ultrasound at first ultrasound element 230A (or vice versa) to determine whether the stimulation obtained a resulting contraction of right atrium 205.
FIG. 6 is a schematic drawing, similar to FIGS. 2 and 5, illustrating generally, by way of example, but not by way of limitation, another embodiment of portions of system 100 in which device 105 also includes a third ultrasonic element 235. This embodiment also illustrates, by way of example, locating third ultrasonic element 235 in a header portion extending from the hermetically sealed case. Alternatively, third ultrasonic element 235 is located in the hermetically sealed case, as illustrated in FIG. 2. In th embodiment of FIG. 6, a stimulation is delivered to right ventricle 200, and its movement is detected by providing ultrasound at first ultrasound element 230A and receiving the ultrasound at third ultrasound element 235 (or vice versa) to determine whether the stimulation obtained a resulting contraction of right ventricle 200. Similarly, a stimulation is delivered to right atrium 205, and its movement is detected by providing ultrasound at second ultrasound element 230B and receiving the ultrasound at third ultrasound element 235 (or vice versa) to determine whether the stimulation obtained a resulting contraction of right atrium 205.
FIG. 7 is a schematic drawing illustrating another embodiment of portions of system 100 in which a single ultrasound element, such as first ultrasound element 230, both provides and receives ultrasound energy. In this embodiment, first ultrasound element 230 is coupled to driver 300. Ultrasound element 230 converts electrical energy provided by driver 300 into an ultrasound energy pulse that is delivered to heart 115. Then, driver 300 is turned off, and ultrasound element 230 receives reflected ultrasound energy, such as from any acoustic boundary, for example, the interior wall of heart 115. The ultrasound energy reflected from the heart wall and received by ultrasound element 230 is transduced by ultrasound element 230 into an electrical signal that is provided, at node/bus 305 to signal processor 310.
In one embodiment, variations in the transit time of the received ultrasound energy that is reflected from the heart wall provides an indication of the movement of the heart due to a contraction. In another embodiment, variations in the Doppler shift of the received ultrasound energy that is reflected from the heart wall provides an indication of the movement of the heart due to a contraction. In a further embodiment, both transit time and Doppler shift measurements (or other like measurements) are used. Using the techniques described above, system 100 includes an ultrasound autocapture method that determines whether a particular pacing stimulation captured the heart based on the ultrasound indication of movement of the heart during a time window following the pacing stimulation.
Although it is described above primarily with respect to using ultrasound for providing autocapture capability, system 100 includes also other uses, as illustrated generally, by way of example, but not by way of limitation, in the schematic drawing of FIG. 8. In a first example, the ultrasound signal provides information about mechanical heart contractions. The ultrasound signal is transduced and processed to obtain an electrical signal that includes information about the heart contractions. From the slope other characteristics of this electrical signal, a slope detection module 800 determines the strength of the heart contraction. In one embodiment, the slope detection module 800 is implemented as a sequence of instructions executed by signal processor 310. For example, stronger contractions occur during a shorter period of time, corresponding to a larger slope in the ultrasonically transduced mechanical heart contraction signal. This information is used for diagnostic purposes (e.g., communicated to programmer 125) or to adjust therapy, such as by adjusting rate, timing, or energy to maximize the strength of the heart contraction.
In a second example, the ultrasound signal provides information about mechanical heart contractions. Intrinsic electrical heart activity signals obtained, at sensing circuit 815, from the lead electrodes. These intrinsic electrical heart activity signals are also referred to as electrogram signals. The electrogram signals provide information about the electrical heart activity which causes the heart contractions. The ultrasound and the electrogram signals are compared by a dissociation detection module 805 implemented as a sequence of instructions executed in signal processor 310 to determine whether, and to what degree, there exists any dissociation between the time of intrinsic electrical heart activity and the corresponding resulting mechanical contractions of the heart. This information is used for diagnostic purposes (e.g., communicated to programmer 125) or to adjust therapy, such as by adjusting rate, timing, or energy delivered to optimize the relationship between intrinsic electrical heart activity and the mechanical contractions of the heart.
In a third example, the ultrasound signal provides information about mechanical heart contractions. The ultrasound signal is transduced and processed to obtain an electrical signal that includes information about the heart contractions. From the amplitude or other characteristics of this signal, the filling and end diastolic volume of the heart is determined. In one example, a amplitude detection module 810, such as a peak detection module implemented as a sequence of instructions executed in signal processor 310, is used to obtain an indirect measure of the volume of the heart using amplitude measurements. This information is used for diagnostic purposes (e.g., communicated to programmer 125). For example, increases in heart volume may indicate degeneration toward congestive heart failure (CHF). Alternatively, the ultrasonic signal information is used to adjust therapy, such as by adjusting rate, timing, or energy delivered to maximize cardiac output or efficiency.
In a fourth example, the ultrasound signal provides information about mechanical heart contractions. Electrogram signals, from sensing circuit 815, provide information about the electrical heart activity that causes the heart contractions. Such electrogram signals may include far-field sensing of electrical heart activity associated with heart chambers other than the heart chamber in which the electrode providing the signal is located. The ultrasonically obtained heart contraction information is used to augment the electrical heart activity information from sensing circuit 815 for better determining the origin of the sensed electrical heart activity (e.g., near-field or far-field) so that therapy can be provided based on a more accurate determination of heart activity. Conversely, the ultrasound signal may include components associated with heart chambers other than the heart chamber associated with the ultrasound element. In such a case, the electrogram information may alternatively be used to better determine the origin of the ultrasonically-indicated mechanical heart contraction signal so that therapy can be provided based on a more accurate determination of heart activity.
In a fifth example, the ultrasound signal provides information about mechanical heart contractions. Electrogram signals from sensing circuit 815 provide information about the electrical heart activity that causes the heart contractions. Certain arrhythmias, such as sinus tachycardia and ventricular tachycardia are difficult to distinguish from each other based on electrogram signals. Moreover, defibrillation countershock therapy may be appropriate for a ventricular tachycardia, but unnecessary for a sinus tachycardia. However, the mechanical heart contraction signal characteristics are different for sinus tachycardia as compared to ventricular tachycardia. In one embodiment, system 100 discriminates between sinus tachycardia, ventricular tachycardia, and other arrhythmias based on the mechanical heart contraction signal obtained from one or more ultrasound elements disposed in one or more of right ventricle 200, right atrium 205, or other heart chamber. Anti-tachyarrhythmia therapy is tailored to the particular type of arrhythmia detected. In one embodiment, defibrillation countershocks are delivered for ventricular tachyarrhythmias, but are not delivered for sinus tachyarrhythmias. System 100 saves energy by avoiding the inappropriate delivery of defibrillation countershocks for sinus tachyarrhythmias. This minimizes the risk and expense to patient 120 associated with early explantation and replacement of device 105. Avoiding inappropriate delivery of defibrillation countershocks also avoids irritating the heart and causing further arrhythmias. Even more importantly, system 100 decreases the risk of actually causing a ventricular tachyarrhythmia, such as life-threatening ventricular fibrillation, by inappropriately delivering a shock.
In a sixth example, the signal processor 310 controls operation of endocardial ultrasonic element 225 such that it delivers localized ultrasound energy pulses to at least partially disrupt cell membranes near the pacing tip electrode 220. This is expected to lower the pacing threshold energy required to capture the heart 115 by decreasing the electrical resistance of cell membranes near the pacing electrode. One or more pacing pulses are then delivered at reduced energies, such as by using the autocapture techniques described above. This prolongs the usable life of implanted device 105. In one embodiment, delivery of the ultrasound energy pulse is synchronized to delivery of a pacing pulse.
In a seventh example, the signal processor 310 controls operation of endocardial ultrasonic element 225 such that it modulates the release of a steroid from a nearby steroid eluting element, such as a polymeric steroid eluting matrix. In one example, a steroid eluting matrix is associated with nearby pacing electrode 220 to reduce the formation of scar tissue after implant so that lower pacing threshold energies are obtained. In one embodiment, device 105 delivers ultrasound energy to enhance the rate of steroid delivery. Because device 105 can accurately control the timing, duration, and energy of the ultrasound, increased control is obtained over the release of the steroid, which is ordinarily governed primarily by the physical characteristics of the steroid eluting matrix. In one embodiment, device 105 is programmably operated to release the steroid either more immediately after implant or after a desired time delay.
In an eighth example, the endocardial ultrasonic element 225 is used to measure blood flow in the heart chamber in which it is disposed, using transit time, Doppler shift, or other measurement techniques. This blood flow information is used for diagnostic purposes or to adjust therapy, such as by adjusting rate, timing, or energy delivered to maximize cardiac output based on the blood flow measurements.
The above-described system provides, among other things, a cardiac rhythm management system with ultrasound autocapture capability for determining whether a stimulation has evoked a desired response from the heart, and for adjusting an energy of the stimulation based on the observed response from the heart. An autocapture determination circuit determines whether motion of the heart chamber indicates a contraction in response to the stimulation, and adjusts the stimulation energy to provide only that energy which is needed to obtain capture. This saves energy, prolonging the life of the implanted device, minimizing the risk and expense to a patient associated with early explantation and replacement of the implanted device.
Although the system was described above primarily with respect to disposing an ultrasound element in the right ventricle for autocapture determination, it is understood that the system also includes application to ultrasonic autocapture determination in other heart chambers, and to the use of ultrasound for applications other than autocapture, some of which are described above.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4357944Oct 8, 1980Nov 9, 1982Rudolf MauserCardiotachometerUS4651716Nov 1, 1985Mar 24, 1987Canadian Patents And Development LimitedMethod and device for enhancement of cardiac contractilityUS4881549Jul 14, 1988Nov 21, 1989Marquette ElectronicsApparatus and method for obtaining ultrasonic backcatter measurement from tissueUS4917115Jul 11, 1988Apr 17, 1990Vitatron Medical B. V.Pacing system and method for physiological stimulation of the heart utilizing Doppler meansUS4936304Dec 16, 1987Jun 26, 1990Thomas Jefferson UniversityPacing system and method for cardiac pacing as a function of determined myocardial contractilityUS5139020Mar 8, 1991Aug 18, 1992Telectronics Pacing Systems, Inc.Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniquesUS5156154Mar 8, 1991Oct 20, 1992Telectronics Pacing Systems, Inc.For monitoring performance of a patient's heartUS5156157Mar 8, 1991Oct 20, 1992Telectronics Pacing Systems, Inc.Catheter-mounted doppler ultrasound transducer and signal processorUS5183040Mar 8, 1991Feb 2, 1993Telectronics Pacing Systems, Inc.Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control systemUS5188106Mar 8, 1991Feb 23, 1993Telectronics Pacing Systems, Inc.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasoundUS5197467Jun 22, 1992Mar 30, 1993Telectronics Pacing Systems, Inc.Multiple parameter rate-responsive cardiac stimulation apparatusUS5220924Nov 6, 1991Jun 22, 1993Frazin Leon JDoppler-guided retrograde catheterization using transducer equipped guide wireUS5243976Mar 25, 1991Sep 14, 1993Ferek Petric BozidarTricuspid flow synchronized cardiac electrotherapy system with blood flow measurement transducer and controlled pacing signals based on blood flow measurementUS5305745Apr 2, 1992Apr 26, 1994Fred ZacoutoDevice for protection against blood-related disorders, notably thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the bloodUS5316001Feb 22, 1993May 31, 1994Ferek Petric BozidarCardiac measurement system for measuring blood flow velocity by use of a sensor implanted inside the heartUS5508045Feb 18, 1994Apr 16, 1996The Regents Of The University Of CaliforniaAdministering nitric oxide donorUS5527336Mar 2, 1995Jun 18, 1996Boston Scientific CorporationMethod of treating the symptoms of a flow obstruction of a urethraUS5544656Dec 2, 1994Aug 13, 1996The Regents Of The University Of CaliforniaMethod and apparatus for myocardial wall measurementUS5546949Mar 16, 1995Aug 20, 1996Frazin; LeonMethod and apparatus of logicalizing and determining orientation of an insertion end of a probe within a biotic structureUS5609612Dec 13, 1995Mar 11, 1997Sorin Biomedica Cardio S.P.A.Device for determining myocardial function and corresponding procedure and methodUS5657760Jan 11, 1996Aug 19, 1997Board Of Regents, The University Of Texas SystemApparatus and method for noninvasive doppler ultrasound-guided real-time control of tissue damage in thermal therapyUS5676162Jun 7, 1995Oct 14, 1997Electric Boat CorporationReciprocating pump and linear motor arrangementUS5676651Feb 25, 1994Oct 14, 1997Electric Boat CorporationSurgically implantable pump arrangement and method for pumping body fluidsUS5693091Jun 7, 1995Dec 2, 1997Electric Boat CorporationArtificial heart and method of maintaining blood flowUS5702430Jun 7, 1995Dec 30, 1997Electric Boat CorporationSurgically implantable power supplyUS5722419Nov 30, 1994Mar 3, 1998Semmlow; John L.System for determining the viability of tissueUS5727552Jan 11, 1996Mar 17, 1998Medtronic, Inc.Catheter and electrical lead location systemUS5738096Feb 1, 1996Apr 14, 1998Biosense, Inc.Cardiac electromechanicsUS5749831Jun 23, 1997May 12, 1998Baker; Donald A.Fetal cardiac monitoring utilizing umbilical blood flow parameters and heartbeat informationUS5752971Jun 5, 1995May 19, 1998Boston Scientific Technology, Inc.Method of treating a flow obstructionUS5758666Jun 7, 1995Jun 2, 1998Electric Boat CorporationReciprocating pump with imperforate pistonUS5792199Jul 24, 1997Aug 11, 1998Pacesetter, Inc.Pacemaker having rate responsive transducer and method for operating sameUS5814599Aug 4, 1995Sep 29, 1998Massachusetts Insitiute Of TechnologyApplying a patch to the skin which delivers therapeutic dosagesUS5830848May 25, 1995Nov 3, 1998The Regents Of The University Of CaliforniaMethod and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancyUS5836985Sep 18, 1997Nov 17, 1998The Regents Of The University Of MichiganMethod for treating abnormal arial or ventricular activityUS5843129Jun 7, 1995Dec 1, 1998Electric Boat CorporationElectrical circuit for equipment requiring redundant flow paths and method of useUS5865738Oct 21, 1994Feb 2, 1999Regents Of The University Of CaliforniaTissue viability monitorUS5879375Jun 7, 1995Mar 9, 1999Electric Boat CorporationImplantable device monitoring arrangement and methodUS5925069Nov 7, 1997Jul 20, 1999Sulzer Intermedics Inc.Removing conformal insulative material from implantable medical device using excimer laserUS5948771Jun 6, 1996Sep 7, 1999The Trustees Of Columbia University In The City Of New YorkMethod for treating heart failure using tetrapyrroles and metallotetrapyrrolesUS5991660Jun 9, 1998Nov 23, 1999The Regents Of The University Of MichiganCardiac pacing methodsUS6024703May 7, 1997Feb 15, 2000Eclipse Surgical Technologies, Inc.Ultrasound device for axial rangingUS6216027Dec 16, 1997Apr 10, 2001Cardiac Pathways CorporationSystem for electrode localization using ultrasoundUS6277077Nov 16, 1998Aug 21, 2001Cardiac Pathways CorporationCatheter including ultrasound transducer with emissions attenuationUS6398736Oct 20, 1999Jun 4, 2002Mayo Foundation For Medical Education And ResearchParametric imaging ultrasound catheterUS6421565Jul 30, 1998Jul 16, 2002Pacesetter AbCardiac monitoring device and a rate responsive pacemaker systemUS6443894Sep 29, 1999Sep 3, 2002Acuson CorporationMedical diagnostic ultrasound system and method for mapping surface data for three dimensional imagingUS6450977Nov 17, 2000Sep 17, 2002CervilenzDevices and methods for cervix measurementUS6491639Apr 5, 2000Dec 10, 2002Pacesetter, Inc.Extravascular hemodynamic sensorEP0503285A1Feb 10, 1992Sep 16, 1992Telectronics N.V.A catheter-mounted doppler ultrasound transducer and signal processorEP0503839A2Mar 5, 1992Sep 16, 1992Telectronics N.V.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasoundWO1995019806A1Jan 24, 1995Jul 27, 1995Bozidar Ferek PetricCardiac electrotherapy system synchronized with venous flowWO1998038911A1Mar 6, 1998Sep 11, 1998Marshall EdgeA system for sharing electrocardiogram electrodes and transducersWO1999007285A1Jul 30, 1998Feb 18, 1999Hemmingsson TryggveA cardiac monitoring device and a rate responsive pacemaker systemNon-Patent CitationsReference1"Realtime Position Management-Tracking Technology", Cardiac Pathways Corporation, www.cardiac.com/products_systems.html,(2001), 2 pgs.2"Realtime Position Management�Tracking Technology", Cardiac Pathways Corporation, www.cardiac.com/products_systems.html,(2001), 2 pgs.3Ben-Haim, Shlomo A., "Catheter Navigation in Modern Electrophysiology", Journal of Cardiovascular Electrophysiology, vol., No. 11, (Nov. 2000), 1193-1195.4De Groot, Natasja M., et al., "Three-Dimensional Catheter Positioning During Radiofrequency Ablation in Patients: First Application of a Real-Time Position Management System", Journal of Cardiovascular Electrophysiology, vol. 11, No. 11,, (Nov. 2000), 1183-1192.Referenced byCiting PatentFiling datePublication dateApplicantTitleUS7731658Aug 16, 2007Jun 8, 2010Cardiac Pacemakers, Inc.Glycemic control monitoring using implantable medical deviceUS7985254Jan 8, 2008Jul 26, 2011David TolkowskyEndobronchial fluid exhaler devices and methods for use thereofUS8196580May 10, 2007Jun 12, 2012Yossi GrossImplantable respiration therapy deviceUS8521282Nov 30, 2007Aug 27, 2013Biotronik Crm Patent AgImplantable medical system with acoustic sensor to measure mitral blood flowUS8688216Nov 26, 2012Apr 1, 2014Cardiac Pacemakers, Inc.Autothreshold with sensing from pacing cathodeUS20100010354 *Jul 6, 2009Jan 14, 2010Olaf SkerlImplantable ultrasonic measurement arrangementEP2158938A1Aug 27, 2009Mar 3, 2010Biosense Webster, Inc.Pacemaker with position sensing* Cited by examinerClassifications U.S. Classification607/28International ClassificationA61N1/365Cooperative ClassificationA61N1/36528European ClassificationA61N1/365B4Legal EventsDateCodeEventDescriptionSep 19, 2011FPAYFee paymentYear of fee payment: 8Jan 7, 2008REMIMaintenance fee reminder mailedDec 31, 2007FPAYFee paymentYear of fee payment: 4RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services